ConductScience.org, home

Paper39374239

Targeting of oxidized Macrophage Migration Inhibitory Factor (oxMIF) with antibody ON104 attenuates the severity of glomerulonephritis.

Ferhat M and 9 others. PLoS One, 2024. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Targeting of oxidized Macrophage Migration Inhibitory Factor (oxMIF) with antibody ON104 attenuates the severity of glomerulonephritis. Papers, record 39374239. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39374239

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Targeting of oxidized Macrophage Migration Inhibitory Factor (oxMIF) with antibody ON104 attenuates the severity of glomerulonephritis.
PubMed
Journal
PLoS One
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.42, provisional
iCite
Revised in PubMed
2026-10-01
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ferhat MMarouahttps://orcid.org/0000-0002-1298-4620
2Mayer JJulia
3Costa LHLyndon H
4Prendecki MMaria
5Tarazona AAPAlejandro A Puchol
6Schinagl AAlexanderhttps://orcid.org/0000-0002-6060-969X
7Kerschbaumer RJRandolf J
8Tam FWKFrederick W K
9Landlinger CChristine
10Thiele MMichaelhttps://orcid.org/0000-0002-3003-9999

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Macrophage Migration-Inhibitory FactorsMajor topic
GlomerulonephritisMajor topic
Animals
Rats
Humans
Male
Rats, Inbred WKY
Disease Models, Animal
Rabbits
Macrophages
Neutrophils
Kidney
Oxidation-Reduction
Antibodies, Neutralizing

Source PubMed

Download CSV of topics

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132207164Phase I study of imalumab (BAX69), a fully human recombinant antioxidized macrophage migration inhibitory factor antibody in advanced solid tumours.Br J Clin Pharmacol2020https://conductscience.org/library/papers/32207164PubMed
231414920Macrophage migration inhibitory factor (MIF) as a therapeutic target for rheumatoid arthritis and systemic lupus erythematosus.Expert Opin Ther Targets2019https://conductscience.org/library/papers/31414920PubMed
322127710Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.Arthritis Rheum2011https://conductscience.org/library/papers/22127710PubMed
410435873Development of scarring and renal failure in a rat model of crescentic glomerulonephritis.Nephrol Dial Transplant1999https://conductscience.org/library/papers/10435873PubMed
530358918MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor as a Possible Indicator of Response to Therapy in Membranous Nephropathy.Proteomics Clin Appl2019https://conductscience.org/library/papers/30358918PubMed
627425855The incidence, prevalence, and outcomes of glomerulonephritis derived from a large retrospective analysis.Kidney Int2016https://conductscience.org/library/papers/27425855PubMed
78988336Identification and immunohistochemical localization of macrophage migration inhibitory factor in human kidney.Biochem Mol Biol Int1996https://conductscience.org/library/papers/8988336PubMed
826611548Corticosteroids: Mechanisms of Action in Health and Disease.Rheum Dis Clin North Am2016https://conductscience.org/library/papers/26611548PubMed
926858715Macrophage Migration Inhibitory Factor in Clinical Kidney Disease.Front Immunol2016https://conductscience.org/library/papers/26858715PubMed
1017890747Glomerular glucocorticoid receptor expression is reduced in late responders to steroids in adult-onset minimal change disease.Nephrol Dial Transplant2008https://conductscience.org/library/papers/17890747PubMed
1117314328
Inhibition of p38 mitogen-activated protein kinase is effective in the treatment of experimental crescentic glomerulonephritis and suppresses monocyte chemoattractant protein-1 but not IL-1beta or IL-6.
J Am Soc Nephrol2007https://conductscience.org/library/papers/17314328PubMed
1229475991Glucocorticoids in the Treatment of Glomerular Diseases: Pitfalls and Pearls.Clin J Am Soc Nephrol2018https://conductscience.org/library/papers/29475991PubMed
1335091838Macrophage migration inhibitory factor family proteins are multitasking cytokines in tissue injury.Cell Mol Life Sci2022https://conductscience.org/library/papers/35091838PubMed
1432132388The glomerular crescent: triggers, evolution, resolution, and implications for therapy.Curr Opin Nephrol Hypertens2020https://conductscience.org/library/papers/32132388PubMed
1537579967The newly engineered monoclonal antibody ON104, targeting the oxidized Macrophage Migration Inhibitory Factor (oxMIF), ameliorates clinical and histopathological signs of collagen-induced arthritis.Eur J Pharmacol2023https://conductscience.org/library/papers/37579967PubMed
1636180072OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases.J Immunother Cancer2022https://conductscience.org/library/papers/36180072PubMed
1727636991Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer.Oncotarget2016https://conductscience.org/library/papers/27636991PubMed
1830241958MIF Matters: The Macrophage Migration Inhibitory Factor and Kidney Injury.Am J Kidney Dis2019https://conductscience.org/library/papers/30241958PubMed
1911792756Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis.J Am Soc Nephrol2002https://conductscience.org/library/papers/11792756PubMed
2031608058MiRNA Regulation of MIF in SLE and Attenuation of Murine Lupus Nephritis With miR-654.Front Immunol2019https://conductscience.org/library/papers/31608058PubMed

See all 43 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
42465767Macrophage migration inhibitory factor in atrial fibrillation.Front Immunol2026https://conductscience.org/library/papers/42465767

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39374239

GET https://conductscience.org/api/papers/v1/39374239/references?page=2